Hi-tech tool manufacturer Oxford Instruments said first half pre-tax profit fell to £12.5m from £13.2m the year before but sees an improved second half.
The group, which makes and supplies tools and systems with a focus on research and industrial applications, said revenue surged over 40% in a 'robust' market environment and as it introduced new products.
Revenue for the six months to 30 September 2011 rose 41% to £159m with organic growth of 30%. Adjusted profit before tax rose to £18.7m from £10.6m before.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Order intake rose 24% to £175m in the six-month period. Oxford saw continued growth in China with orders up 53%.
Chairman Nigel Keen said, "Our broad spread of geographies and technologies, and our strong pipeline of new products should help us to remain resilient in the event of a global economic downturn. We are continuing our active pursuit of acquisitions that have the potential to enhance shareholder value and add to our range of technical capabilities."
"Trading since the period end has remained strong and the Board believes that performance in the second half of the year is likely to exceed that of the first half," he added.
The company, which recently bought US medical firm Platinum Medical Imaging, said its acquisitions of Omicron NanoTechnology and Omniprobe in June are integrating well and performing to plan.
The interim dividend has been lifted 10% to 2.77p.
--
cj
-
Going part-time could leave a £58,000 hole in your pension: how to plug the gapThere are many reasons for switching to part-time work, but some savers don’t consider the impact on their pension until it is too late
-
Three bargain investment trusts to add to your portfolioThese three investment trusts are bargains compared to their net asset value (NAV), but one fund analyst thinks the deep discounts are unwarranted.
